로딩 중…
지수 로딩 중…
하이텍팜
106190· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩13,700+0.15%
2026-06-19
Price Chart
하이텍팜+6.12%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 145.67B KRW |
| Revenue | 69.05B KRW |
| Net Income | 9.02B KRW |
| Total Assets | 145.35B KRW |
| Net Assets | 128.81B KRW |
| Employees | 125 |
| Value | |
| P/E | 16.14x |
| P/B | 1.13x |
| P/S | 2.11x |
| EV/EBITDA | 14.97x |
| FCF Yield | 10.37% |
| Profitability | |
| ROE | 7.01% |
| ROA | 6.21% |
| Op. Margin | 13.32% |
| Revenue Growth | -7.42% |
| Earnings Growth | -112.23% |
| Financial Health | |
| Debt Ratio | 112.84% |
| Total Debt | 0 KRW |
| FCF | 15.10B KRW |
| Cash | 7.98B KRW |
| Current Ratio | 4.62x |
| Net Debt/EBITDA | -0.87x |
| Dividend | |
| Div. Yield | 1.10% |
| Div. Growth | 50.00% |
| Performance | |
| 1Y Return | 6.12% |
| 1M Return | -11.04% |
| From 52W High | -45.20% |
| 1Y MDD | -45.28% |
| Trading | |
| Volume | 74,991 shares |
| Foreign Own. | 46.81% |
| Per Share | |
| EPS | 849 KRW |
| BPS | 12,115 KRW |
Company Info
Hitech Pharm, established in 1998 and headquartered in Chungju, Chungcheongbuk-do, is a specialized enterprise for antibiotic raw pharmaceutical ingredients, listed on KOSDAQ in 2010. It primarily produces Carbapenem-class antibiotics, with main products Imipenem and Ertapenem, which are high-priced due to their high antibacterial activity, and largely exported to Europe and Asia. The company possesses Carbapenem-class antibiotic technology achieving higher yields and lower impurities than competitors, fostering its growth in the global market via next-generation production plants.